ProAxsis News, Events and Company Research Updates

ProAxsis launches updated Active Proteinase 3 Immunoassay Enhanced sensitivity enables researchers...

ProAxsis Targets Growth in the COPD Market with Imperial College London...

ProAxsis Transformed Into Independently Funded Growth Company New EIS fundraise to...

Leadership Transition, Operational Expansion and Growth ProAxsis Enters New Growth Phase...

ProAxsis Strengthens Supply Chain for Diagnostic Tests ProAxsis Strengthens Supply Chain...

Insmed Clinical Programme Support from ProAxsis ProAxsis Biomarker Technology Supports Major...

Randox Science Park Relocation and ProAxsis Expansion ProAxsis Expands Operations with...

Future Medicines Institute and ProAxsis Collaboration ProAxsis partners with Future Medicines...

CPI Collaboration Supporting ProAxsis Diagnostic Innovation ProAxsis and CPI Collaborate to...

ProAxsis Strengthens Board and Updates Company Strategy To expedite Point of...

Measuring bone health with a new innovation for patients at high...

ProAxsis Announces Additional Key Company Appointments As part of its continuing...

ProAxsis establishes new internal Finance team admin January 6, 2022 Recent...

ProAxsis Limited appoints first distributor for DACH region admin December 14,...

ProAxsis Limited appoints distributor for key North America region admin November...

NetScientific acquires 100% control of portfolio company ProAxsis Limited admin October...

ProAxsis investing in R&D to create new diagnostic tests for chronic...

ProAxsis announces new appointments admin June 23, 2020 Recent Posts ProAxsis...

New data demonstrates high potential of NEATstik® as a rapid point-of-care...

ProAxsis enhances portfolio with new CE Marked Immunoassay admin August 2,...

ProAxsis reports first NEATstik® sale admin February 15, 2018 Recent Posts...

ProAxsis Launches ProteaseTag® Active Plasmin Immunoassay following CE Mark registration admin...

ProAxsis provides update on commercialisation progress admin November 21, 2017 Recent...

ProAxsis appoints first distributor for NE Immunoassay admin September 14, 2017...

ProAxsis registers European CE Mark for first neutrophil elastase point-of-care test...

ProAxsis technology highlighted in AJRCCM editorial admin May 17, 2017 Recent...

ProAxsis gains CE Mark for Active Neutrophil Elastase Immunoassay admin September...

https://youtu.be/0aOfgJKQPHU ProAxsis CEO David Ribeiro was interviewed by ProActive Investors UK....